Form D · Biotechnology
Amicrobe, Inc.
Carlsbad, CA · CIK 0001513330
Offering snapshot reported Apr 25, 2024 · SEC filing
- Reported sold
- $5M Offering amount: $5M
- Investors reported
- 51 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 20, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 25, 2024 | Initial | $5,000,003 | No comparison | 51 | SEC filing |
| Apr 25, 2024 | Initial | $16,740,243 | No comparison | 32 | SEC filing |
| Feb 22, 2011 | Initial | $999,987 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-511583
Source: Form D, filed Apr 25, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Bevilacqua | Director, Executive |
| Joseph Boystak | Director, Executive |
| Martin Burns | Director |
| Albert Carnesale | Director |
| Michael Flesch | Director, Executive |
| Scott Hayashi | Executive |
| Daniel Huang | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3142 Tiger Run Court Suite 101
Carlsbad, CA, 92010
Carlsbad, CA, 92010